SEC Form 4 · accession 0001193125-26-306742
Korro Bio, Inc. · KRRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Oliver Dolan
Officer — Senior Vice President, Finance
Period of report
Jul 15, 2026
Accepted (ET)
Jul 17, 2026 · 7:11 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001703647
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 15, 2026 | A | 5,500 | $0.00 | A | 23,599 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of common stock issuable upon settlement of a restricted stock unit (RSU) granted under the Issuer's 2023 Stock Option and Incentive Plan (the 2023 Plan) that will vest as follows: 50% on July 15, 2027 and 50% on July 15, 2028, in each case subject to the reporting person maintaining a continuous Service Relationship (as defined in the 2023 Plan) through each such date.
- F2Includes 16,241 shares of common stock issuable upon settlement of restricted stock units (RSUs) that remain unvested, consisting of 10,741 shares that will vest on December 15, 2026, 2,750 shares that will vest on July 15, 2027, and 2,750 shares that will vest on July 15, 2028, in each case subject to the reporting person maintaining a continuous Service Relationship (as defined in the 2023 Plan) through each such date.